Literature DB >> 35680135

Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD.

Swapnil Hiremath1, Michaeline McGuinty2, Christos Argyropoulos3, K Scott Brimble4,5, Pierre Antoine Brown6, Zain Chagla4, Rebecca Cooper5,7, Stephanie Hoar6, David Juurlink8, Darin Treleaven4,7, Michael Walsh9,10,11, Angie Yeung5, Peter Blake5,12.   

Abstract

Entities:  

Keywords:  COVID-19; chronic kidney disease; dialysis; drug metabolism; pharmacokinetics; transplantation

Mesh：

Substances：

Year:  2022        PMID： 35680135      PMCID： PMC9435977          DOI： 10.2215/CJN.05270522

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  8 in total

Review 1.  The Exclusion of Patients with CKD in Prospectively Registered Interventional Trials for COVID-19-a Rapid Review of International Registry Data.

Authors:  Rupert Major; Haresh Selvaskandan; Yahya Mostafa Makkeyah; Katherine Hull; Apexa Kuverji; Matthew Graham-Brown
Journal:  J Am Soc Nephrol       Date:  2020-09-08       Impact factor: 10.121

2.  Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.

Authors:  Delphine Planas; Nell Saunders; Piet Maes; Florence Guivel-Benhassine; Cyril Planchais; Julian Buchrieser; William-Henry Bolland; Françoise Porrot; Isabelle Staropoli; Frederic Lemoine; Hélène Péré; David Veyer; Julien Puech; Julien Rodary; Guy Baele; Simon Dellicour; Joren Raymenants; Sarah Gorissen; Caspar Geenen; Bert Vanmechelen; Tony Wawina-Bokalanga; Joan Martí-Carreras; Lize Cuypers; Aymeric Sève; Laurent Hocqueloux; Thierry Prazuck; Félix A Rey; Etienne Simon-Loriere; Timothée Bruel; Hugo Mouquet; Emmanuel André; Olivier Schwartz
Journal:  Nature       Date:  2021-12-23       Impact factor: 49.962

3.  Outcomes of COVID-19 in CKD Patients: A Multicenter Electronic Medical Record Cohort Study.

Authors:  Haig Pakhchanian; Rahul Raiker; Amrita Mukherjee; Ahmad Khan; Shailendra Singh; Arka Chatterjee
Journal:  Clin J Am Soc Nephrol       Date:  2021-02-08       Impact factor: 8.237

4.  COVID-19 in patients undergoing long-term dialysis in Ontario.

Authors:  Leena Taji; Doneal Thomas; Matthew J Oliver; Jane Ip; Yiwen Tang; Angie Yeung; Rebecca Cooper; Andrew A House; Phil McFarlane; Peter G Blake
Journal:  CMAJ       Date:  2021-02-04       Impact factor: 8.262

5.  Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.

Authors:  Jennifer Hammond; Heidi Leister-Tebbe; Annie Gardner; Paula Abreu; Weihang Bao; Wayne Wisemandle; MaryLynn Baniecki; Victoria M Hendrick; Bharat Damle; Abraham Simón-Campos; Rienk Pypstra; James M Rusnak
Journal:  N Engl J Med       Date:  2022-02-16       Impact factor: 176.079

6.  Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.

Authors:  Edward J Carr; Andreas Kronbichler; Matthew Graham-Brown; Graham Abra; Christos Argyropoulos; Lorraine Harper; Edgar V Lerma; Rita S Suri; Joel Topf; Michelle Willicombe; Swapnil Hiremath
Journal:  Kidney Int Rep       Date:  2021-07-06

7.  Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.

Authors: 
Journal:  Lancet       Date:  2022-03-10       Impact factor: 202.731
  8 in total
  3 in total

1.  Sotrovimab in SARS-COV-2 chronic hemodialysis patients in the Omicron era. Is intradialytic administration feasible? Report of 4 cases.

Authors:  Emanuele Mambelli; Lorenzo Gasperoni; Laura Maldini; Carlo Biagetti; Angelo Rigotti
Journal:  J Nephrol       Date:  2022-09-13       Impact factor: 4.393

Review 2.  The Pharmacist's Role in Managing COVID-19 in Chronic Kidney Disease Patients: A Review of Existing Strategies and Future Implications.

Authors:  Mohammed Salim Karattuthodi; Shabeer Ali Thorakkattil; Suhaj Abdulsalim; Sathvik Belagodu Sridhar; Sainul Abideen Parakkal; Savera Arain; Hafees Madathil; Ajmal Karumbaru Kuzhiyil; Mamdouh Mohammed Ahmed Ageeli; Mazhuvanchery Kesavan Unnikrishnan
Journal:  Pharmacy (Basel)       Date:  2022-08-05

3.  Renalism.

Authors:  Swapnil Hiremath
Journal:  CMAJ       Date:  2022-08-02       Impact factor: 16.859
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.